ListedSME

Himalaya Nutravedics IPO GMP History

Final pre-listing GMP reading: 28 Sept 2026, 5:55 am IST

Final GMP (pre-listing)₹0
Implied Return (pre-listing)+0.0%
Listing Price₹118actual debut
Listing Gain+11.3%↑ vs issue price

GMP applies before listing only. The figures below are a historical record of grey market sentiment ahead of the debut on 29 Sept 2026 — see listing performance for the actual outcome.

GMP trend

GMP moved from ₹0 on 16 Sept 2026 to ₹0 on 28 Sept 2026.

Day-wise GMP history

DateGMPImplied ReturnSubject to SaudaImplied Listing
28 Sept 2026₹0+0.0%₹0₹106
27 Sept 2026₹0+0.0%₹0₹106
26 Sept 2026₹0+0.0%₹0₹106
25 Sept 2026₹0+0.0%₹0₹106
24 Sept 2026₹0+0.0%₹0₹106
23 Sept 2026₹0+0.0%₹0₹106
22 Sept 2026₹0+0.0%₹0₹106
21 Sept 2026₹0+0.0%₹0₹106
20 Sept 2026₹0+0.0%₹0₹106
19 Sept 2026₹0+0.0%₹0₹106
18 Sept 2026₹0+0.0%₹0₹106
16 Sept 2026₹0+0.0%—₹106

GMP is an unofficial figure sourced from grey market dealers and is not a guarantee of the listing price. Provided for information only, not investment advice. How we source GMP · Disclaimer

Reading this GMP history

How the GMP moved

Our tracking of the Himalaya Nutravedics IPO's grey market premium starts at ₹0, recorded on 16 Sept 2026. The final reading before listing was ₹0, dated 28 Sept 2026. Across that 13-day window, the premium ended exactly where it began. All 12 day-end readings held at ₹0 — an unusually steady grey market for this issue.

GMP versus the actual listing

At ₹0, the last pre-listing premium pointed to a debut around ₹106 on an issue price of ₹106. The stock actually debuted at ₹118, a listing gain of +11.3% on the issue price. That puts the actual debut ₹12 above what the final premium implied — a gap worth noting when weighing how much signal GMP carried for this issue.

Kostak and subject-to-sauda

Dealers in this issue were also pricing whole applications, not just shares. The subject-to-sauda rate — what a buyer pays for an application that is honoured only if it wins allotment — was last quoted at ₹0 per application as of 28 Sept 2026. Unlike a kostak deal, where an application changes hands at a fixed price regardless of the outcome, a sauda payout depends entirely on the allotment draw. At the prevailing premium, the dealer-estimated profit per lot stood at ₹0 on a lot of 1200 shares. Both metrics come from the same dealer network as the GMP itself and move with it. Every grey market figure on this page is an unofficial number collected from grey-market dealers; it is not published by the company or the exchanges and is not a guarantee of the actual listing price.

Frequently asked questions

What is the Himalaya Nutravedics IPO price band?
The Himalaya Nutravedics IPO price band is ₹100 to ₹106 per share, with a lot size of 1200 shares.
What was the Himalaya Nutravedics IPO GMP before listing?
The final grey market premium recorded before the Himalaya Nutravedics IPO listed was ₹0. The IPO listed on 29 Sept 2026 at ₹118, +11.3% against the issue price. GMP is an unofficial figure and was never a guarantee of the listing price.
When is the Himalaya Nutravedics IPO allotment and listing date?
Allotment is expected on 25 Sept 2026. The shares are scheduled to list on 29 Sept 2026 on BSE.